Switch to:
More From Other Websites
Pain Therapeutics, Inc. :PTIE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 Jun 08 2016
Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY® May 19 2016
DURECT Announces FDA Advisory Committee Meeting for REMOXY® May 19 2016
Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY® May 19 2016
PAIN THERAPEUTICS INC Financials May 17 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 12 2016
Pain Therapeutics to Present New REMOXY Data At American Pain Society Meeting May 11 2016
DURECT Announces New REMOXY® Data being Presented at American Pain Society Meeting May 11 2016
DRRX: Update on First Quarter Financials May 06 2016
Pain Therapeutics reports 1Q loss May 05 2016
Pain Therapeutics reports 1Q loss May 05 2016
Pain Therapeutics Reports Q1 2016 Financial Results May 05 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 05 2016
Pain Therapeutics Reports Q1 2016 Financial Results May 05 2016
Pain Therapeutics Gains 7%, FDA Has Accepted Company's Remoxy For Review Apr 13 2016
DURECT Announces FDA Acceptance of REMOXY® NDA, PDUFA Date of September 25, 2016 Apr 12 2016
FDA Accepts REMOXY NDA for Review, Sets PDUFA Date of September 25, 2016 Apr 12 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 12 2016
FDA Accepts REMOXY NDA for Review, Sets PDUFA Date of September 25, 2016 Apr 12 2016
DRRX: REMOXY® NDA Resubmitted Mar 30 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK